Abstract
The constitutive androstane receptor (CAR, NR1I3) is responsible for the transcription of multiple drug metabolizing enzymes and transporters. There are two possible methods of activation for CAR, direct ligand binding and a ligand-independent method, which makes this a unique nuclear receptor. Both of these mechanisms require translocation of CAR from the cytoplasm into the nucleus. Interestingly, CAR is constitutively active in immortalized cell lines due to the basal nuclear location of this receptor. This creates an important challenge in most in vitro assay models because immortalized cells cannot be used without inhibiting the high basal activity. In this book chapter, we go into detail of how to perform quantitative high-throughput screens to identify hCAR1 modulators through the employment of a double stable cell line. Using this line, we are able to identify activators, as well as deactivators, of the challenging nuclear receptor, CAR.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Honkakoski P, Zelko I, Sueyoshi T, Negishi M (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18(10):5652–5658
Wang H, LeCluyse E (2003) Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin Pharmacokinet 42(15):1331–1357. doi:10.2165/00003088-200342150-00003
Lynch C, Pan Y, Li L, Heyward S, Moeller T, Swaan PW, Wang H (2014) Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes. Toxicol Appl Pharmacol 279(1):33–42, doi: http://dx.doi.org/10.1016/j.taap.2014.05.009
Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. 106. doi:10.1073/pnas.0909731106
Chen T, Tompkins LM, Li L, Li H, Kim G, Zheng Y, Wang H (2010) A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3. J Pharmacol Exp Ther 332(1):106–115
Li H, Chen T, Cottrell J, Wang H (2009) Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-Human Constitutive Androstane Receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes. Drug Metab Dispos 37(5):1098–1106. doi:10.1124/dmd.108.026005
Zelko I, Sueyoshi T, Kawamoto T, Moore R, Negishi M (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol 21(8):2838–2846. doi:10.1128/mcb.21.8.2838-2846.2001
Huang W, Zhang J, Wei P, Schrader WT, Moore DD (2004) Meclizine is an agonist ligand for mouse Constitutive Androstane Receptor (CAR) and an inverse agonist for human CAR. Mol Endocrinol 18(10):2402–2408. doi:10.1210/me.2004-0046
Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, Wang H (2008) The peripheral benzodiazepine receptor ligand 1-(2-Chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 74(2):443–453. doi:10.1124/mol.108.046656
Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275(20):15122–15127. doi:10.1074/jbc.M001215200
Lau AJ, Yang G, Rajaraman G, Baucom CC, Chang TKH (2011) Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor. J Pharmacol Exp Ther 336(3):816–826. doi:10.1124/jpet.110.175927
Mäkinen J, Frank C, Jyrkkärinne J, Gynther J, Carlberg C, Honkakoski P (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 62(2):366–378. doi:10.1124/mol.62.2.366
Toell A, Kröncke K-D, Kleinert H, Carlberg C (2002) Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J Cell Biochem 85(1):72–82. doi:10.1002/jcb.10104
Freitas J, Miller N, Mengeling BJ, Xia M, Huang R, Houck K, Rietjens IMCM, Furlow JD, Murk AJ (2014) Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform. Curr Chem Genomics Transl Med 8:36–46. doi:10.2174/2213988501408010036
Shukla SJ, Sakamuru S, Huang R, Moeller TA, Shinn P, VanLeer D, Auld DS, Austin CP, Xia M (2011) Identification of clinically used drugs that activate pregnane X receptors. Drug Metab Dispos 39(1):151–159. doi:10.1124/dmd.110.035105
Lynch C, Zhao J, Huang R, Xiao J, Li L, Heyward S, Xia M, Wang H (2015) Quantitative High-Throughput Identification of Drugs as Modulators of Human Constitutive Androstane Receptor. Sci Rep 5. doi:10.1038/srep10405. http://www.nature.com/srep/2015/150520/srep10405/abs/srep10405.html#supplementary-information
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lynch, C., Zhao, J., Wang, H., Xia, M. (2016). Quantitative High-Throughput Luciferase Screening in Identifying CAR Modulators. In: Zhu, H., Xia, M. (eds) High-Throughput Screening Assays in Toxicology. Methods in Molecular Biology, vol 1473. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6346-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6346-1_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6344-7
Online ISBN: 978-1-4939-6346-1
eBook Packages: Springer Protocols